JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4626
Northern Trust Morningstar Global Upstream Natural Resources ETF
GUNR
$6.98B
| $125K | ﹤0.01% |
3,823
-241
| -6% | -$7.69K |
2018 Q2
3 quarters
|
|
4627
Alaunos Therapeutics
TCRT
$2.02M
| $124K | ﹤0.01% |
215
-10
| -4% | -$4.18K |
2016 Q4
9 quarters
|
|
4628
CALL
Viavi Solutions
VIAV
$11.6B
| $124K | ﹤0.01% |
+10,000
| New | +$117K |
2019 Q1
0 quarters
|
|
|
ORBC
4629
DELISTED
ORBCOMM, Inc.
ORBC
| $123K | ﹤0.01% |
18,076
-614
| -3% | -$4.91K |
2017 Q3
6 quarters
|
|
|
STKL
4630
DELISTED
SunOpta
STKL
| $121K | ﹤0.01% |
35,123
+13,900
| +65% | +$53.8K |
2017 Q2
7 quarters
|
|
|
DQ
4631
Daqo New Energy
DQ
$747M
| $120K | ﹤0.01% |
18,205
-307,145
| -94% | -$2M |
2017 Q2
7 quarters
|
|
|
FENG
4632
Phoenix New Media
FENG
$17.2M
| $120K | ﹤0.01% |
4,743
+661
| +16% | +$15.1K |
2015 Q4
13 quarters
|
|
4633
iShares Russell Top 200 ETF
IWL
$2.27B
| $120K | ﹤0.01% |
1,834
-66
| -3% | -$4.17K |
2016 Q4
9 quarters
|
|
4634
NewtekOne
NEWT
$322M
| $120K | ﹤0.01% |
6,088
-46,279
| -88% | -$899K |
2015 Q4
13 quarters
|
|
4635
Peapack-Gladstone Financial
PGC
$786M
| $119K | ﹤0.01% |
4,548
-132
| -3% | -$3.62K |
2017 Q4
5 quarters
|
|
|
STML
4636
DELISTED
Stemline Therapeutics, Inc.
STML
| $119K | ﹤0.01% |
9,289
+2,067
| +29% | +$23.4K |
2017 Q3
6 quarters
|
|
|
BKS
4637
DELISTED
Barnes & Noble
BKS
| $119K | ﹤0.01% |
21,950
-143,682
| -87% | -$875K |
2013 Q2
23 quarters
|
|
4638
ENI
E
$78.4B
| $118K | ﹤0.01% |
3,370
+1,798
| +114% | +$61K |
2013 Q2
23 quarters
|
|
|
JCP
4639
DELISTED
J.C. Penney Company, Inc.
JCP
| $118K | ﹤0.01% |
79,550
-3,601
| -4% | -$5.07K |
2013 Q2
23 quarters
|
|
4640
Biglari Holdings Class A
BH.A
$1.16B
| $117K | ﹤0.01% |
160
+7
| +5% | +$4.69K |
2018 Q2
3 quarters
|
|
4641
PUT
Coherus Oncology
CHRS
$173M
| $117K | ﹤0.01% |
+8,600
| New | +$115K |
2019 Q1
0 quarters
|
|
|
HIL
4642
DELISTED
Hill International, Inc. Common Stock
HIL
| $117K | ﹤0.01% |
+40,110
| New | +$128K |
2019 Q1
0 quarters
|
|
|
MXIM
4643
CALL
DELISTED
Maxim Integrated Products
MXIM
| $117K | ﹤0.01% |
2,200
-44,900
| -95% | -$2.41M |
2018 Q3
2 quarters
|
|
4644
CNB Financial Corp
CCNE
$1.01B
| $116K | ﹤0.01% |
4,589
-936
| -17% | -$24.3K |
2017 Q4
5 quarters
|
|
4645
Global X SuperDividend REIT ETF
SRET
$204M
| $116K | ﹤0.01% |
2,567
+67
| +3% | +$2.96K |
2018 Q4
1 quarter
|
|
|
PGNX
4646
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $116K | ﹤0.01% |
24,812
-181,699
| -88% | -$822K |
2017 Q4
5 quarters
|
|
|
WAIR
4647
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $116K | ﹤0.01% |
13,222
-620
| -4% | -$5.1K |
2017 Q4
5 quarters
|
|
4648
Kura Oncology
KURA
$945M
| $115K | ﹤0.01% |
6,903
-325
| -4% | -$5.01K |
2017 Q3
6 quarters
|
|
|
CYBE
4649
DELISTED
Cyberoptics Corp
CYBE
| $115K | ﹤0.01% |
+6,710
| New | +$133K |
2019 Q1
0 quarters
|
|
4650
WisdomTree Emerging Markets Corporate Bond Fund
EMCB
$96M
| $114K | ﹤0.01% |
1,604
+4
| +0.3% | +$280 |
2016 Q1
12 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.